Skip to content

Chronic Presence of Epstein Barr Virus in Sulcular and Junctional Epithelial Tissue From Gingiva is Associated With Severe Periodontitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01246648
Enrollment
6
Registered
2010-11-23
Start date
2011-01-17
Completion date
2015-04-01
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parodontitis Aggressive, Parodontitis Chronic

Brief summary

The etiopathogenesis of periodontal disease results from complex interaction between infectious agents, mainly including bacteria, and host cellular and humoral immune responses. However it is thought that bacteria-induced pathogenesis is not sufficient alone to explain all biological and clinical features of the destructive periodontal disease. The main hypothesis is that herpesviruses, such as Epstein-Barr Virus, may participate as well by altering epithelial gingival cell biology and consequently may promote the initiation and progression of periodontitis.

Interventions

PROCEDUREBiopsy

dental extraction and gingival epithelial biopsy

PROCEDUREbiopsy

dental extraction and gingival epithelial biopsy

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
12 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men exclusively * 12 years minimum * 2 patients affected by chronic periodontitis * 2 patients affected by aggressive periodontitis * 2 healthy patients (orthodontics extraction) * Subject who have read and understood the information note relative under investigation and who have signed the informed consent * Subject whose legal representative signed the parental consent (if minor patient)

Exclusion criteria

* Patient with contre-indication to dental extraction * Patient witn serious blood disease * Patient who exhibits systemic condition incompatible with the realization of the study * Patient treated with oral retinoids, bisphosphonates, oral anticoagulants and anticonvulsivants * Patient who presents za buccal carcinoma treated with radiotherapy * Patient who have received during the past 6 months: anti-inflammatory drugs, anti-cancerous or immunosuppressive chemiotherapy * Patient who presents a linguistic or psychic incapacity to understand information * Female patient

Design outcomes

Primary

MeasureTime frame
Presence/absence of EBV in the epithelial cells of periodontal pockets (by Immunofluorescence and in situ Hybridizationat time = 0 (baseline)

Secondary

MeasureTime frame
Presence/ absence of latency and/or lytic proteins (by immunofluorescence and in situ hybridizationat time = 0 (baseline)
- Epithelial tissue infected (by Immunofluorescence and In situ Hybridization) : detection of oral gingival epithelium, sulcular epithelium, junctional epithelium.at time = 0 (baseline)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026